Japan· JP-6132408E1034
セフメタゾールナトリウム
A cefmetazole product containing セフメタゾールナトリウム, registered in Japan by アルフレッサファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- セフメタゾールナトリウム
- Manufacturer
- アルフレッサファーマ
- Country
- Japan (JP)
- ATC code
- J01DC09
- ATC class
- Cefmetazole
- Defined daily dose
- 4 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for cefmetazole.
Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefmetazole · interactions on record
25 records
- 25 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01DC09
Cefmetazole, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99363f29-067b-4b16-a184-c4a68b1dbfc5 GET /v1/drugs/99363f29-067b-4b16-a184-c4a68b1dbfc5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５００ｍｇ１瓶（溶解液付）",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6132408E1034",
"category": "注射薬",
"price_yen": 727,
"generic_name": "セフメタゾールナトリウム",
"product_name_jp": null,
"therapeutic_class": "6132",
"transitional_expiry": null
}See everything about cefmetazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.